예시 분류1
Retatrutide
- 5mg*10vials USD 45.00
- 10mg*10vials USD 85.00
참고가입니다. 결제 전에 컨시어지가 금액을 확인합니다.
4.2 / 5 · 3675 개주문을 보낸 뒤 컨시어지에게 연락할 때 주문 번호를 알려 주십시오.
제품 특징
Triple receptor agonist, offering the most potent fat-loss effect (24% weight reduction in clinical settings)
제품 소개
Retatrutide is an investigational triple-receptor agonist peptide (targeting GLP-1, GIP, and glucagon receptors) currently under development for the treatment of obesity and type 2 diabetes. Phase II clinical trials have demonstrated significant weight loss, with patients in the high-dose group achieving a weight reduction of up to 24% over 48 weeks. This educational program outlines a once-weekly subcutaneous administration regimen, incorporating a gradual dose-escalation approach to minimize gastrointestinal side effects.
주의사항
Reconstitution: Add 1.0 mL of bacteriostatic water → ~ 5.0 mg/mL concentration
Typical weekly dosage range: 2–8 mg once weekly (gradually increased over 8–12 weeks)
Easy measurement: At 5.0 mg/mL, 1 unit = 0.01 mL ≈ 50 mcg (using a U-100 insulin syringe)
사용 방법
1. Draw 1.0 mL of bacteriostatic water using a sterile syringe.
2. Inject slowly along the inner wall of the vial; avoid creating foam.
3. Gently swirl or roll the vial until the contents are dissolved (do not shake).
4. Label with the date and store refrigerated at 2–8°C, protected from light.
5. Use within 4 weeks of reconstitution.
보관 방법
Lyophilized: Store at -20°C or lower; stable for up to 24 months.
After reconstitution: Store at 2–8°C; use within 4 weeks.
Allow the vial to reach room temperature before opening to minimize condensation.
리뷰
4.2 / 5
3675 개
최근 100개를 표시합니다.
-
★★★★★
VX8•••••••5207
독일
2026-10-18 16:47
Shipping took a little longer than I expected. The product matched the page. No problem with the contents.
-
★★★★★
VX0•••••••6A7C
미국
2026-10-18 12:54
Delivery was on time. The storage note was easy to follow. No issues on arrival.
-
★★★★★
VXD•••••••0C6F
캐나다
2026-10-18 09:01
Tracking updated a day late. What I ordered was inside. Not perfect, but honest.
-
★★★★★
VXD•••••••8281
독일
2026-10-18 05:09
Notice of dispatch came a day later than I hoped. The item itself was fine. The product side was correct.
-
★★★★★
VXE•••••••33A6
프랑스
2026-10-18 01:16
The handoff at the depot was slow. The label matched the listing. The delay was minor.
-
★★★★★
VX8•••••••DA6F
호주
2026-10-17 21:23
Communication was brief. The batch note was readable. I would still order again.
-
★★★★★
VXB•••••••3C9F
미국
2026-10-17 17:31
Support took longer to reply than I hoped. The paperwork matched. A fair outcome once it arrived.
-
★★★★★
VX2•••••••B86F
한국
2026-10-17 13:38
I had to wait longer than the page suggested. The spec line was accurate. Packing protected the contents.
-
★★★★★
VX5•••••••D7A9
미국
2026-10-17 09:45
The tracking page paused for a day. The paperwork was correct. I have no complaint about the contents.
-
★★★★★
VXB•••••••FB9B
기타
2026-10-17 05:53
Communication was brief. The vial was undamaged. A fair delivery overall.
구매자 리뷰
주문할 때 사용한 주문 번호와 전화번호를 입력하세요. 둘 다 이 상품이 포함된 주문과 일치해야 합니다.
다른 진열 상품
예시 분류1
Cagrilintide
Cagrilintide is a long-acting, acylated amylin analogue—a pancreatic hormone—designed for once-weekly subcutaneous injection. It activates central amylin receptors, promoting satiety, slowing gastric emptying, and reducing food intake. In Phase 2 and Phase 3 clinical trials, cagrilintide induced dose-dependent weight loss, with side effects primarily being gastrointestinal in nature.
참고가USD 113.00
예시 분류1
CJC-1295+IPA(CP10)
This formulation combines CJC-1295 (without DAC)—a modified growth hormone-releasing hormone (GHRH) analog—with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (without DAC) produces a sustained, dose-dependent increase in GH and IGF-1 levels, while Ipamorelin selectively stimulates GH release without increasing ACTH or cortisol.
참고가USD 116.00
예시 분류1
Tirzepatide
Tirzepatide is a dual incretin receptor agonist composed of 39 amino acids. It activates both GLP-1 and GIP receptors, thereby enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite. With a half-life of approximately 5 days, it is convenient to administer via a once-weekly subcutaneous injection. Clinical trials have demonstrated that tirzepatide offers superior efficacy in terms of glycemic control and weight loss compared to selective GLP-1 receptor agonists.
참고가USD 40.00
예시 분류1
Tesamorelin
Tesamorelin is a synthetic 44-amino acid peptide analog that resembles growth hormone-releasing hormone (GHRH). It stimulates the release of endogenous growth hormone and increases IGF-1 levels, thereby promoting lipolysis and providing metabolic benefits. Tesamorelin has been approved by the FDA for the reduction of visceral adipose tissue in individuals with HIV-associated lipodystrophy.
참고가USD 41.00